合肥拓锐生物科技有限公司是一家专业的新药开发,新药研发公司

Chinese | English

新药研发首页 > Patents Transfer > Patents Transfer projects
Patents Transfer projects
Mesylate imatinib
2012-4-5

Mesylate imatinib  bulk drugs and pills and capsules

We provide skill&technology transfer of Mesylate imatinib finished products / new plant building guidance ;

We also provide these pills  if you need finish product;

 

Ⅰ:Name:           Mesylate imatinib  

Ⅱ:Formulations: pills/capsules or bulk  drugs

Ⅲ:Specs:         as  requirement;

Ⅳ:Indications:   Used to treat chronic myeloid leukemia (CML) in acute transformation phase, accelerated phase ;or for the patients with chronic phase after failure of α-interferon therapy; unresectable or metastasis of malignant gastrointestinal stromal tumors (GIST) patients

合肥网站建设 合肥网络推广 合肥seo优化 合肥网络营销 新药研发 药物研发 新药转让